Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(152)
•••
Comment by Hankerchiefon May 09, 2020 12:49pm
89 Views
Post# 31007082

RE:RE:RE:RE:RE:TLT

RE:RE:RE:RE:RE:TLT
anabelsi wrote:

Yeah, the device devision should have been sold off ages ago and the focus should have been entirely on their cancer division. It has been nothing but waste for all these years!

How TLT brands themselves is also just dumb honestly. Look at their site:
https://theralase.com/

Cancer is mentioned twice on the home page, everything else is about their lasers and main parts of the page mention nothing but their laser devices - no real mention of their cancer devision, no mention of their successes or the current trials.

While the research team is great, management sure isn't. Either way, they now have more than enough cash to fully fund the trial. I swear if they dilliute again management should be fired.



That is interesting regarding the website.  If the cancer technology legally can be mentioned on the site then it should be good to go front page with it.  I wonder why they are not doing that?  Good point.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities